Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuball

Showing results (221-230 of 256) with videos related to

Pageof 26
Sort By:
Science Translational Medicine|May 8, 2020
Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1Johanna M Eberhard, Mathieu Angin, Caroline Passaes, et al.
Nature Immunology|November 27, 2023
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cellsPatricia Hernández-López, Eline van Diest, Peter Brazda, et al.
Bone Marrow Transplantation|August 5, 2023
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMTRémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Leukemia|April 4, 2015
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cellsL C J Te Boome, C Mansilla, L E van der Wagen, et al.
Bone Marrow Transplantation|November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTKavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Bone Marrow Transplantation|August 29, 2019
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factorsJan Styczyński, Gloria Tridello, Linda Koster, et al.
Bone Marrow Transplantation|January 10, 2024
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Diderik-Jan Eikema, Linda Koster, et al.
Blood Advances|October 6, 2019
Identification of a tumor-specific allo-HLA-restricted γδTCRG J J Kierkels, W Scheper, A D Meringa, et al.
Bone Marrow Transplantation|May 1, 2021
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMTMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Pageof 26

Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
Science Translational Medicine|May 8, 2020
Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1Johanna M Eberhard, Mathieu Angin, Caroline Passaes, et al.
Nature Immunology|November 27, 2023
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cellsPatricia Hernández-López, Eline van Diest, Peter Brazda, et al.
Bone Marrow Transplantation|August 5, 2023
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMTRémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Leukemia|April 4, 2015
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cellsL C J Te Boome, C Mansilla, L E van der Wagen, et al.
Bone Marrow Transplantation|November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTKavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Bone Marrow Transplantation|August 29, 2019
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factorsJan Styczyński, Gloria Tridello, Linda Koster, et al.
Bone Marrow Transplantation|January 10, 2024
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Diderik-Jan Eikema, Linda Koster, et al.
Blood Advances|October 6, 2019
Identification of a tumor-specific allo-HLA-restricted γδTCRG J J Kierkels, W Scheper, A D Meringa, et al.
Bone Marrow Transplantation|May 1, 2021
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMTMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Pageof 26